The global Novel Cancer Diagnostic Solutions market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Hardware Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Novel Cancer Diagnostic Solutions include Philips Healthcare, Thermo Fisher Scientific, Abbott Laboratories, BD, Siemens Healthineers, PHC Holdings, Agilent, Sakura Finetek and Epredia, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Novel Cancer Diagnostic Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Cancer Diagnostic Solutions. This report contains market size and forecasts of Novel Cancer Diagnostic Solutions in global, including the following market information:
Global Novel Cancer Diagnostic Solutions Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Novel Cancer Diagnostic Solutions companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Cancer Diagnostic Solutions Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Novel Cancer Diagnostic Solutions Market Segment Percentages, by Type, 2023 (%)
Hardware
Software and Services
Global Novel Cancer Diagnostic Solutions Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Novel Cancer Diagnostic Solutions Market Segment Percentages, by Application, 2023 (%)
Hospital & Diagnostic Centers
Laboratories & Research Institutes
Global Novel Cancer Diagnostic Solutions Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Novel Cancer Diagnostic Solutions Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Cancer Diagnostic Solutions revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Novel Cancer Diagnostic Solutions revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Philips Healthcare
Thermo Fisher Scientific
Abbott Laboratories
BD
Siemens Healthineers
PHC Holdings
Agilent
Sakura Finetek
Epredia
bioMeriux
MDx Health
DiaSorin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Novel Cancer Diagnostic Solutions, market overview.
Chapter 2: Global Novel Cancer Diagnostic Solutions market size in revenue.
Chapter 3: Detailed analysis of Novel Cancer Diagnostic Solutions company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Novel Cancer Diagnostic Solutions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Novel Cancer Diagnostic Solutions Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Cancer Diagnostic Solutions Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Cancer Diagnostic Solutions Overall Market Size
2.1 Global Novel Cancer Diagnostic Solutions Market Size: 2023 VS 2030
2.2 Global Novel Cancer Diagnostic Solutions Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Novel Cancer Diagnostic Solutions Players in Global Market
3.2 Top Global Novel Cancer Diagnostic Solutions Companies Ranked by Revenue
3.3 Global Novel Cancer Diagnostic Solutions Revenue by Companies
3.4 Top 3 and Top 5 Novel Cancer Diagnostic Solutions Companies in Global Market, by Revenue in 2023
3.5 Global Companies Novel Cancer Diagnostic Solutions Product Type
3.6 Tier 1, Tier 2 and Tier 3 Novel Cancer Diagnostic Solutions Players in Global Market
3.6.1 List of Global Tier 1 Novel Cancer Diagnostic Solutions Companies
3.6.2 List of Global Tier 2 and Tier 3 Novel Cancer Diagnostic Solutions Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Novel Cancer Diagnostic Solutions Market Size Markets, 2023 & 2030
4.1.2 Hardware
4.1.3 Software and Services
4.2 By Type - Global Novel Cancer Diagnostic Solutions Revenue & Forecasts
4.2.1 By Type - Global Novel Cancer Diagnostic Solutions Revenue, 2019-2024
4.2.2 By Type - Global Novel Cancer Diagnostic Solutions Revenue, 2025-2030
4.2.3 By Type - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Novel Cancer Diagnostic Solutions Market Size, 2023 & 2030
5.1.2 Hospital & Diagnostic Centers
5.1.3 Laboratories & Research Institutes
5.2 By Application - Global Novel Cancer Diagnostic Solutions Revenue & Forecasts
5.2.1 By Application - Global Novel Cancer Diagnostic Solutions Revenue, 2019-2024
5.2.2 By Application - Global Novel Cancer Diagnostic Solutions Revenue, 2025-2030
5.2.3 By Application - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Novel Cancer Diagnostic Solutions Market Size, 2023 & 2030
6.2 By Region - Global Novel Cancer Diagnostic Solutions Revenue & Forecasts
6.2.1 By Region - Global Novel Cancer Diagnostic Solutions Revenue, 2019-2024
6.2.2 By Region - Global Novel Cancer Diagnostic Solutions Revenue, 2025-2030
6.2.3 By Region - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Novel Cancer Diagnostic Solutions Revenue, 2019-2030
6.3.2 US Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.3.3 Canada Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.3.4 Mexico Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Novel Cancer Diagnostic Solutions Revenue, 2019-2030
6.4.2 Germany Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.4.3 France Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.4.4 U.K. Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.4.5 Italy Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.4.6 Russia Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.4.7 Nordic Countries Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.4.8 Benelux Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Novel Cancer Diagnostic Solutions Revenue, 2019-2030
6.5.2 China Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.5.3 Japan Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.5.4 South Korea Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.5.5 Southeast Asia Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.5.6 India Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Novel Cancer Diagnostic Solutions Revenue, 2019-2030
6.6.2 Brazil Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.6.3 Argentina Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Novel Cancer Diagnostic Solutions Revenue, 2019-2030
6.7.2 Turkey Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.7.3 Israel Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.7.4 Saudi Arabia Novel Cancer Diagnostic Solutions Market Size, 2019-2030
6.7.5 UAE Novel Cancer Diagnostic Solutions Market Size, 2019-2030
7 Novel Cancer Diagnostic Solutions Companies Profiles
7.1 Philips Healthcare
7.1.1 Philips Healthcare Company Summary
7.1.2 Philips Healthcare Business Overview
7.1.3 Philips Healthcare Novel Cancer Diagnostic Solutions Major Product Offerings
7.1.4 Philips Healthcare Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.1.5 Philips Healthcare Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Novel Cancer Diagnostic Solutions Major Product Offerings
7.2.4 Thermo Fisher Scientific Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Novel Cancer Diagnostic Solutions Major Product Offerings
7.3.4 Abbott Laboratories Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 BD
7.4.1 BD Company Summary
7.4.2 BD Business Overview
7.4.3 BD Novel Cancer Diagnostic Solutions Major Product Offerings
7.4.4 BD Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.4.5 BD Key News & Latest Developments
7.5 Siemens Healthineers
7.5.1 Siemens Healthineers Company Summary
7.5.2 Siemens Healthineers Business Overview
7.5.3 Siemens Healthineers Novel Cancer Diagnostic Solutions Major Product Offerings
7.5.4 Siemens Healthineers Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.5.5 Siemens Healthineers Key News & Latest Developments
7.6 PHC Holdings
7.6.1 PHC Holdings Company Summary
7.6.2 PHC Holdings Business Overview
7.6.3 PHC Holdings Novel Cancer Diagnostic Solutions Major Product Offerings
7.6.4 PHC Holdings Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.6.5 PHC Holdings Key News & Latest Developments
7.7 Agilent
7.7.1 Agilent Company Summary
7.7.2 Agilent Business Overview
7.7.3 Agilent Novel Cancer Diagnostic Solutions Major Product Offerings
7.7.4 Agilent Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.7.5 Agilent Key News & Latest Developments
7.8 Sakura Finetek
7.8.1 Sakura Finetek Company Summary
7.8.2 Sakura Finetek Business Overview
7.8.3 Sakura Finetek Novel Cancer Diagnostic Solutions Major Product Offerings
7.8.4 Sakura Finetek Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.8.5 Sakura Finetek Key News & Latest Developments
7.9 Epredia
7.9.1 Epredia Company Summary
7.9.2 Epredia Business Overview
7.9.3 Epredia Novel Cancer Diagnostic Solutions Major Product Offerings
7.9.4 Epredia Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.9.5 Epredia Key News & Latest Developments
7.10 bioMeriux
7.10.1 bioMeriux Company Summary
7.10.2 bioMeriux Business Overview
7.10.3 bioMeriux Novel Cancer Diagnostic Solutions Major Product Offerings
7.10.4 bioMeriux Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.10.5 bioMeriux Key News & Latest Developments
7.11 MDx Health
7.11.1 MDx Health Company Summary
7.11.2 MDx Health Business Overview
7.11.3 MDx Health Novel Cancer Diagnostic Solutions Major Product Offerings
7.11.4 MDx Health Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.11.5 MDx Health Key News & Latest Developments
7.12 DiaSorin
7.12.1 DiaSorin Company Summary
7.12.2 DiaSorin Business Overview
7.12.3 DiaSorin Novel Cancer Diagnostic Solutions Major Product Offerings
7.12.4 DiaSorin Novel Cancer Diagnostic Solutions Revenue in Global Market (2019-2024)
7.12.5 DiaSorin Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Novel Cancer Diagnostic Solutions Market Opportunities & Trends in Global Market
Table 2. Novel Cancer Diagnostic Solutions Market Drivers in Global Market
Table 3. Novel Cancer Diagnostic Solutions Market Restraints in Global Market
Table 4. Key Players of Novel Cancer Diagnostic Solutions in Global Market
Table 5. Top Novel Cancer Diagnostic Solutions Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Novel Cancer Diagnostic Solutions Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Novel Cancer Diagnostic Solutions Revenue Share by Companies, 2019-2024
Table 8. Global Companies Novel Cancer Diagnostic Solutions Product Type
Table 9. List of Global Tier 1 Novel Cancer Diagnostic Solutions Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Cancer Diagnostic Solutions Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Novel Cancer Diagnostic Solutions Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Novel Cancer Diagnostic Solutions Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Novel Cancer Diagnostic Solutions Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Novel Cancer Diagnostic Solutions Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Novel Cancer Diagnostic Solutions Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Novel Cancer Diagnostic Solutions Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2025-2030
Table 30. Philips Healthcare Company Summary
Table 31. Philips Healthcare Novel Cancer Diagnostic Solutions Product Offerings
Table 32. Philips Healthcare Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 33. Philips Healthcare Key News & Latest Developments
Table 34. Thermo Fisher Scientific Company Summary
Table 35. Thermo Fisher Scientific Novel Cancer Diagnostic Solutions Product Offerings
Table 36. Thermo Fisher Scientific Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 37. Thermo Fisher Scientific Key News & Latest Developments
Table 38. Abbott Laboratories Company Summary
Table 39. Abbott Laboratories Novel Cancer Diagnostic Solutions Product Offerings
Table 40. Abbott Laboratories Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 41. Abbott Laboratories Key News & Latest Developments
Table 42. BD Company Summary
Table 43. BD Novel Cancer Diagnostic Solutions Product Offerings
Table 44. BD Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 45. BD Key News & Latest Developments
Table 46. Siemens Healthineers Company Summary
Table 47. Siemens Healthineers Novel Cancer Diagnostic Solutions Product Offerings
Table 48. Siemens Healthineers Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 49. Siemens Healthineers Key News & Latest Developments
Table 50. PHC Holdings Company Summary
Table 51. PHC Holdings Novel Cancer Diagnostic Solutions Product Offerings
Table 52. PHC Holdings Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 53. PHC Holdings Key News & Latest Developments
Table 54. Agilent Company Summary
Table 55. Agilent Novel Cancer Diagnostic Solutions Product Offerings
Table 56. Agilent Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 57. Agilent Key News & Latest Developments
Table 58. Sakura Finetek Company Summary
Table 59. Sakura Finetek Novel Cancer Diagnostic Solutions Product Offerings
Table 60. Sakura Finetek Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 61. Sakura Finetek Key News & Latest Developments
Table 62. Epredia Company Summary
Table 63. Epredia Novel Cancer Diagnostic Solutions Product Offerings
Table 64. Epredia Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 65. Epredia Key News & Latest Developments
Table 66. bioMeriux Company Summary
Table 67. bioMeriux Novel Cancer Diagnostic Solutions Product Offerings
Table 68. bioMeriux Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 69. bioMeriux Key News & Latest Developments
Table 70. MDx Health Company Summary
Table 71. MDx Health Novel Cancer Diagnostic Solutions Product Offerings
Table 72. MDx Health Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 73. MDx Health Key News & Latest Developments
Table 74. DiaSorin Company Summary
Table 75. DiaSorin Novel Cancer Diagnostic Solutions Product Offerings
Table 76. DiaSorin Novel Cancer Diagnostic Solutions Revenue (US$, Mn) & (2019-2024)
Table 77. DiaSorin Key News & Latest Developments
List of Figures
Figure 1. Novel Cancer Diagnostic Solutions Segment by Type in 2023
Figure 2. Novel Cancer Diagnostic Solutions Segment by Application in 2023
Figure 3. Global Novel Cancer Diagnostic Solutions Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Novel Cancer Diagnostic Solutions Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Novel Cancer Diagnostic Solutions Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Novel Cancer Diagnostic Solutions Revenue in 2023
Figure 8. By Type - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 9. By Application - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 10. By Type - Global Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 12. By Application - Global Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 14. By Region - Global Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 15. By Country - North America Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 16. US Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 20. Germany Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 21. France Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 28. China Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 32. India Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 34. Brazil Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Novel Cancer Diagnostic Solutions Revenue Market Share, 2019-2030
Figure 37. Turkey Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Novel Cancer Diagnostic Solutions Revenue, (US$, Mn), 2019-2030
Figure 41. Philips Healthcare Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Thermo Fisher Scientific Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Abbott Laboratories Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. BD Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Siemens Healthineers Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. PHC Holdings Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Agilent Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Sakura Finetek Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Epredia Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. bioMeriux Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. MDx Health Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. DiaSorin Novel Cancer Diagnostic Solutions Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
